# Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

> **NCT06538285** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Nicky Mehtani, MD, MPH** · enrollment: 17 (actual)

## Conditions studied

- Methamphetamine Use Disorder

## Interventions

- **DRUG:** Ketamine
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT06538285
- **Lead sponsor:** Nicky Mehtani, MD, MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-04
- **Primary completion:** 2026-04
- **Final completion:** 2026-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-04-14

## Collaborators

- San Francisco Department of Public Health
- California HIV/AIDS Research Program
- National Center for Advancing Translational Sciences (NCATS)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06538285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06538285, "Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06538285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*